tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Pro Medicus Secures A$10M Imaging Contract with German Medical Centers

Story Highlights
  • Pro Medicus Limited provides advanced imaging solutions for healthcare and research.
  • Pro Medicus wins a 5-year, A$10M contract to enhance imaging at German medical centers.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Pro Medicus Secures A$10M Imaging Contract with German Medical Centers

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

The latest announcement is out from Pro Medicus Limited ( (AU:PME) ).

Pro Medicus Limited has secured a 5-year, A$10 million contract to implement its Visage 7 Enterprise Imaging Platform at University Hospital Heidelberg and the German Cancer Research Institute, among other associated hospitals. This deal expands Pro Medicus’s presence in the European market, replacing and consolidating existing legacy systems to enhance diagnostic and research capabilities, thereby supporting cutting-edge medical research and patient care.

The most recent analyst rating on (AU:PME) stock is a Buy with a A$333.00 price target. To see the full list of analyst forecasts on Pro Medicus Limited stock, see the AU:PME Stock Forecast page.

More about Pro Medicus Limited

Pro Medicus Limited is a leading health imaging company that provides advanced imaging solutions through its European subsidiary, Visage Imaging. The company focuses on delivering ultrafast, scalable imaging platforms that consolidate legacy systems and streamline workflows, primarily serving the healthcare and biomedical research sectors.

Average Trading Volume: 175,371

Technical Sentiment Signal: Buy

Current Market Cap: A$31.79B

For an in-depth examination of PME stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1